License | Jotup

Brazil Potash Receives Mine Installation License to Start Project Construction of the Autazes Potash Project in Brazil

Retrieved on:

Tuesday, April 9, 2024

Mining, Farmer, Amazon, Poultry, Risk, Soybean, Indigenous, Plant, License, Fertilizer, Government

MANAUS, Brazil, April 09, 2024 (GLOBE NEWSWIRE) -- Brazil Potash Corp. (“Brazil Potash” or the “Company”) is excited to announce the Amazon State Environmental Protection Institute (IPAAM), has granted the mine Installation License for the Autazes Potash Project (the “Project”) to the 100% owned Brazilian subsidiary Potassio do Brasil, allowing for construction to commence.

Key Points:

MANAUS, Brazil, April 09, 2024 (GLOBE NEWSWIRE) -- Brazil Potash Corp. (“Brazil Potash” or the “Company”) is excited to announce the Amazon State Environmental Protection Institute (IPAAM), has granted the mine Installation License for the Autazes Potash Project (the “Project”) to the 100% owned Brazilian subsidiary Potassio do Brasil, allowing for construction to commence.
The Company expects to start construction with the awarding of contracts for mine surface works and shaft construction.
Now, with the License approval, Brazil can produce this essential mineral for its farmers in country, by-passing the risk and costs of imports.
Potash is extremely important to efficiently grow food as it strengthens the stem of plants to make them more resilient to stresses caused by drought, extreme temperatures, and insect infestation.

Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchici

Retrieved on:

Wednesday, March 20, 2024

Paragraph, Gout, Vexatious litigation, Shanda, Chronic pain, Settlement, PALO, Justice, Takeda, License, FDA, Federal Trade Commission, Nursing

That litigation arose from Scilex’s filing of a sNDA with the FDA seeking to expand the label for its FDA-approved liquid colchicine product, Gloperba®, a preventive treatment for gout.

Key Points:

That litigation arose from Scilex’s filing of a sNDA with the FDA seeking to expand the label for its FDA-approved liquid colchicine product, Gloperba®, a preventive treatment for gout.
As part of the Settlement Agreement, the Scilex Parties entered into a License Agreement with Takeda granting the Company and its affiliates a non-exclusive license to certain patents owned by Takeda.
The Settlement Agreement is subject to approval by the district court, and by both the Federal Trade Commission and the U.S. Department of Justice, as is required in Paragraph IV patent case settlements.
For more information on Scilex Holding Company, refer to www.scilexholding.com .

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update

Retrieved on:

Thursday, March 14, 2024

As per the respective agreements, each of ABVC and BioLite received 23 million shares of AIBL stock (with an expected value of $10 per share).

Key Points:

As per the respective agreements, each of ABVC and BioLite received 23 million shares of AIBL stock (with an expected value of $10 per share).
The Company entered a cooperation agreement on August 14, 2023, with Zhong Hui Lian He Ji Tuan, Ltd. (“Zhonghui”).
On February 06, 2024, ABVC acquired an additional real estate asset via an equity transfer of 703,495 shares at $3.50 per share to develop plant factories for ABVC’s botanical pipeline.
ABVC hopes the property will ultimately be used as an integrated platform for the global development of the Asian healthcare business and the medical, pharmaceutical, and biotechnology industries.

Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on:

Monday, March 25, 2024

Science, Biotechnology, Research, Pharmaceutical, Health, FDA, Genetics, Clinical Trials, Stoke, Acadia Pharmaceuticals, Therapy, Collaboration, License, Cryptocurrency

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today reported financial results for the full year ended December 31, 2023.

Key Points:

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today reported financial results for the full year ended December 31, 2023.
As of December 31, 2023, Stoke had $201.4 million in cash, cash equivalents, and marketable securities, which is anticipated to fund operations to the end of 2025.
Research and development expenses for the year ended December 31, 2023 were $82.2 million, compared to $77.8 million for 2022.
General and administrative expenses for the year ended December 31, 2023 were $41.3 million, compared to $38.9 million for 2022.

OneTrust Joins LOT Network in Major Step to Promote and Protect Open Innovation

Retrieved on:

Tuesday, March 19, 2024

Transfer, The Lot, PAE, Microsoft, Automation, LOT Network, Intelligence, Internet of things, News, OneTrust, AI, IBM, Cloud computing, License, Patent, Privacy, Cryptocurrency

ATLANTA, March 19, 2024 /PRNewswire/ -- OneTrust, the market-defining leader for trust intelligence, today announced that it has joined LOT Network, the international, non-profit community of companies working together to protect themselves against litigation brought on by patent assertion entities (PAEs, also known as "patent trolls"). OneTrust joining the LOT (License on Transfer) Network's community of 3,700+ companies, including eight of the world's largest cloud providers, is intended to enable OneTrust to protect the interests of the Company against patent assertion entities.

Key Points:

OneTrust joining the LOT (License on Transfer) Network's community of 3,700+ companies, including eight of the world's largest cloud providers, is intended to enable OneTrust to protect the interests of the Company against patent assertion entities.
The LOT Network community is committed to protecting members against costly and frivolous PAE litigation.
"Through our membership in LOT Network, we are joining a group of like-minded organizations that see strong value in protecting the traditional uses of patents, while fostering open innovation for today and the future.
"OneTrust's decision to join LOT Network illustrates its commitment to protecting its business ecosystem and retaining resources to invest in real innovation."

Toyota Maintains Leadership in Automotive Innovation, Top Spot Among Automakers in Annual U.S. Patent Ranking

Retrieved on:

Tuesday, March 12, 2024

Carbon, Bev, ANN, Annual report, Carbon-fiber-reinforced polymers, Patent, Steel, Toyota Motor North America, Research, Transport, License, IPO, Toyota, Wireless, TRD, Intellectual Property Owners Association

The ISO D seat assembly absorbs vehicle inputs vertically and laterally, reducing the overall load and impacts onto the vehicle occupant.

Key Points:

The ISO D seat assembly absorbs vehicle inputs vertically and laterally, reducing the overall load and impacts onto the vehicle occupant.
), thereby enhancing convenience and system integration as well as reducing space needs, cost, and weight of the vehicle.
Globally, Toyota spends approximately $1 million per hour on R&D, to ensure that Toyota rapidly and continuously develops cutting-edge, high-quality, and appealing vehicles and technologies.
This commitment ensures that Toyota not only delivers on the needs of customers but also anticipates its role in future societal progress.

XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value

Retrieved on:

Friday, March 8, 2024

Acquisition, Roche, Blue Owl Capital, License, G&A, CVR, NDA, Video game

EMERYVILLE, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), the biotech royalty aggregator, reported its fourth quarter and full year 2023 financial results and highlighted portfolio activities expected to drive long-term shareholder value.

Key Points:

XOMA recorded total revenues of $1.8 million and $4.8 million for the fourth quarter and full year of 2023, respectively.
General and administrative (“G&A”) expenses were $7.3 million for the fourth quarter and $25.6 million for the full year of 2023.
In the fourth quarter of 2023, G&A expenses included $2.6 million in non-cash stock-based compensation expense, compared with $1.0 million in the fourth quarter of 2022.
In 2023, net loss for the fourth quarter and year ended December 31, 2023, was $20.1 million and $40.8 million, respectively.

CryptoBlox Signs Share Purchase Agreement to Acquire Blockchain Fintech

Retrieved on:

Tuesday, March 5, 2024

License, News, Canadian Securities Exchange, Acquisition, Letter, Digital asset, Indian stock exchange, Blockchain, Agreement, Partnership, Cryptocurrency

Vancouver, B.C., March 05, 2024 (GLOBE NEWSWIRE) -- CryptoBlox Technologies Inc. (the “Company” or “CryptoBlox”) (CSE: BLOX) is pleased to announce that it has entered into a share purchase agreement, dated effective March 4, 2024 (the “Agreement”), to acquire (the “Acquisition”) Blockchain Fintech Unipessoal LDA (“Blockchain Fintech”), a Portuguese corporation that develops blockchain-based financial technologies that help onboard “average users” to the blockchain economy. Pursuant to the Agreement, the Company will acquire 100% of the outstanding shares of Blockchain Fintech for 20,000,000 common shares of the Company, having a deemed value of $11,000,000.

Key Points:

Vancouver, B.C., March 05, 2024 (GLOBE NEWSWIRE) -- CryptoBlox Technologies Inc. (the “Company” or “CryptoBlox”) (CSE: BLOX) is pleased to announce that it has entered into a share purchase agreement, dated effective March 4, 2024 (the “Agreement”), to acquire (the “Acquisition”) Blockchain Fintech Unipessoal LDA (“Blockchain Fintech”), a Portuguese corporation that develops blockchain-based financial technologies that help onboard “average users” to the blockchain economy.
Pursuant to the Agreement, the Company will acquire 100% of the outstanding shares of Blockchain Fintech for 20,000,000 common shares of the Company, having a deemed value of $11,000,000.
On September 28, 2023, the Company announced the execution of a letter of intent with Blockchain Fintech, which contemplated a strategic partnership in which CryptoBlox would acquire the rights to Blockchain Fintech’s digital asset license then under development (the “License”).
Through Blockchain Fintech, the Company intends to build and launch structured digital asset products and blockchain payments services within Portugal and eventually other jurisdictions.

AllFi Technologies, Inc. (AllFi Tech), a Subsidiary of The Crypto Company, Completes License Deal, Paving the way for Expansion of the AllFi Brand

Retrieved on:

Thursday, February 29, 2024

Crypto, CRCW, TCC, Blockchain, Artificial intelligence, Marketing, Tech, Growth, License, Cryptocurrency

Through this strategic move, AllFi Tech has granted exclusive rights to AllFi Holdings LLC for the utilization of the AllFi brand.

Key Points:

Through this strategic move, AllFi Tech has granted exclusive rights to AllFi Holdings LLC for the utilization of the AllFi brand.
In a collaborative effort, AllFi Tech has aligned forces with AllFi Holdings to empower the underbanked and unbanked communities through accessible financial solutions.
“This licensing deal marks a milestone for us,” stated Ron Levy, CEO of The Crypto Company.
“We are proud to empower AllFi Holdings in our mutual mission to reach underserved communities by promoting financial inclusion, while also empowering growth and recognition of the AllFi brand.”
Under the License Agreement, AllFi Tech will receive royalties for the utilization of the AllFi brand.

WLAN Revenues Plummet 26 Percent in 4Q 2023, According to Dell'Oro Group

Retrieved on:

Wednesday, March 6, 2024

Cloud, Y/Y, License, Wireless, Growth, Sale, APS, WLAN, Digestion, Huawei, Telecommunications, Controller, Wireless LAN, Public, IEEE 802.11be, Auction

REDWOOD CITY, Calif., March 6, 2024 /PRNewswire/ -- According to a recently published report from Dell'Oro Group, the trusted source for market information about the telecommunications, security, networks, and data center industries, 2023 was a roller coaster ride for Wireless LAN (WLAN) vendors. Revenues were elevated in the first half of the year but contracted sharply in 4Q 2023. Despite the end-of-year correction, annual WLAN revenues hit a record $10 B.

Key Points:

Revenues were elevated in the first half of the year but contracted sharply in 4Q 2023.
Juniper Networks was an outlier in the WLAN market in 4Q, managing to grow Y/Y and Q/Q despite the difficult market conditions.
The percentage of 4Q 2023 revenues from the sale of Indoor Wi-Fi 6E APs was flat compared to 3Q 2023.
All regions experienced a Y/Y reduction in WLAN revenues, with sales to China contracting the least of all the macro regions.